βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer
Kokkinos, J.; Sharbeen, G.; Ignacio, R. M. C.; Pandzic, E.; Youkhana, J.; Boyer, C.; Haghighi, K. S.; Gunawarman, M.; Goldstein, D.; Gebski, V.; Pajic, M.; Pitiyarachchi, O.; Davis, M. E.; Schulstad, G.; Arkell, O. S. M.; Kopecky, C.; Gonzales-Aloy, E.; Erkan, M.; Morton, J. P.; Kavallaris, M.; Gunning, P. W.; Hardeman, E. C.; Johns, A.; Gill, A. J.; Whan, R. M.; Mawson, A.; Australian Pancreatic Cancer Genome Initiative, ; McCarroll, J. A.; Phillips, P. A.
Show abstract
The microtubule protein, {beta}III-tubulin, has been implicated as a prognostic, pro-survival, and chemoresistance factor in some of the most lethal malignancies including pancreatic ductal adenocarcinoma (PDAC). However, precise survival mechanisms controlled by {beta}III-tubulin in cancer cells are unknown. Here, we report an unexpected role of {beta}III-tubulin as a brake on extrinsic caspase 8-dependent apoptosis in PDAC. We show that {beta}III-tubulin knockdown frees death-receptor DR5 to increase its membrane diffusion, clustering, and activation of cell-death. We demonstrate that {beta}III-ubulin silencing increases sensitivity of PDAC cells to chemotherapeutic and microenvironment-derived extrinsic cell-death signals including TRAIL, TNF, and FasL. Finally, nanoparticle delivery of {beta}III-tubulin siRNA to mouse orthotopic PDAC tumours in vivo and human patient-derived PDAC tumour explants ex vivo increases extrinsic apoptosis and reduces tumour progression. Thus, silencing of {beta}III-tubulin represents an innovative strategy to unleash a suicide signal in PDAC cells and render them sensitive to microenvironment and chemotherapy-derived death signals.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence 94%
- The Second Mitochondrial Activator of Caspases (SMAC) regulates growth, inflammation and mitochondrial integrity in cancer cells 94%
- Drug tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms 94%
Similar papers in this journal
- Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine/Tipiracil) in digestive cancers by overexpressing Thymidine Phosphorylase 95%
- Integrative analysis of patient-derived tumoroids and ex vivo organoid modeling of ARID1A loss in bladder cancer reveals therapeutic molecular targets 94%
- Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer 94%
Similar papers in this journal
- Disassembly of hemidesmosomes promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin into focal adhesions 94%
- The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival 94%
- Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment 94%
Similar papers in this journal
- USP28 enables oncogenic transformation of respiratory cells and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K. 94%
- An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer 94%
- Engineered Extracellular Vesicles Enriched with the miR-214/199a Cluster Enhance the Efficacy of Chemotherapy for Ovarian Cancer 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.